Interestingly, RUNX2 is connected to the RUNX3 gene which is already known to be dysregulated in cutaneous T-cell lymphoma (29), emphasizing the necessity of looking further into this gene as a potential biomarker. The gene discussed is RUNX3; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.